The Cleveland Clinic Foundation

The Cleveland Clinic Foundation was paid $863.55M by Medicaid between Jan 2018 and Dec 2024, across 1579 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 31% of everything it billed.

33Billing provider infoTHE CLEVELAND CLINIC FOUNDATION
CLEVELAND, OH 44195

33aNPI1679525919assigned 05/16/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$863.55M

24GClaims16,016,267

24DCodes billed1579

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#1 of 101

Median peer was paid$22.32M

This provider vs. median39×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,362,709	$57.44M
2019	1,578,774	$64.02M
2020	1,268,654	$62.81M
2021	1,755,736	$86.60M
2022	2,042,399	$99.87M
2023	4,407,896	$278.95M
2024incomplete	3,600,099	$213.85M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	31%	2,534,307	2,108,085	$269.98M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.2%	518,214	448,053	$45.28M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.3%	582,362	517,566	$37.38M
J2350	Injection, ocrelizumab, 1 mg	4.0%	1,801	1,329	$34.27M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.5%	619,198	575,826	$21.59M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.4%	806,649	738,040	$20.33M
J9271	Injection, pembrolizumab, 1 mg	1.7%	1,649	1,042	$14.56M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	1.7%	238,829	206,898	$14.56M
96361	Intravenous infusion, hydration; each additional hour	1.3%	30,936	22,003	$11.30M
J0585	Injection, onabotulinumtoxina, 1 unit	1.2%	13,547	10,607	$10.12M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.0%	101,964	50,594	$8.69M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	75,564	63,480	$7.85M

1567 more codes

99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	90,120	$6.98M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	79,897	$6.68M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	63,706	$6.33M
81513		<1%	40,466	$6.31M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	2,363	$5.87M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	28,386	$5.52M
96127		<1%	57,871	$5.47M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	14,524	$5.20M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	146,885	$5.00M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	34,206	$4.74M
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	34,289	$4.50M
87631		<1%	21,694	$4.46M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	9,136	$4.24M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	86,131	$4.13M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	2,702	$4.06M
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	15,733	$3.93M
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	834	$3.91M
80053	Comprehensive metabolic panel	<1%	302,267	$3.75M
70450	Computed tomography, head or brain; without contrast material	<1%	44,727	$3.66M
20610		<1%	31,755	$3.59M
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	133,359	$3.59M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	32,194	$3.52M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	643	$3.31M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	5,385	$3.22M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	34,846	$3.20M
77386		<1%	6,598	$2.88M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	24,773	$2.87M
76819	Fetal biophysical profile; without non-stress testing	<1%	36,854	$2.84M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	10,144	$2.82M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	22,305	$2.77M
99232	Hospital visit by a doctor, follow-up day	<1%	149,057	$2.69M
99215	Doctor's office visit, returning patient (complex)	<1%	52,079	$2.65M
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	21,361	$2.63M
95720		<1%	23,210	$2.62M
76801		<1%	24,615	$2.61M
95811		<1%	5,776	$2.55M
96415		<1%	7,238	$2.50M
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	454,006	$2.44M
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	55,327	$2.44M
J9299	Injection, nivolumab, 1 mg	<1%	649	$2.40M
J0178	Injection, aflibercept, 1 mg	<1%	2,260	$2.36M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	15,369	$2.35M
67028	Intravitreal injection of a pharmacologic agent	<1%	20,315	$2.34M
64615		<1%	11,417	$2.29M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	16,393	$2.27M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	20,246	$2.22M
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	21,444	$2.15M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	15,824	$2.12M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	18,593	$2.11M
95715		<1%	2,363	$2.09M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,920	$2.03M
59025	Fetal non-stress test	<1%	12,802	$1.90M
G0378	Hospital observation service, per hour	<1%	18,720	$1.80M
95951		<1%	16,273	$1.78M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	3,344	$1.75M
95806		<1%	4,308	$1.74M
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	1,731	$1.74M
90677		<1%	16,875	$1.73M
95886		<1%	8,577	$1.73M
J2323	Injection, natalizumab, 1 mg	<1%	464	$1.72M
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	1,616	$1.68M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,112	$1.68M
92134		<1%	63,789	$1.64M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	982	$1.63M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	10,816	$1.54M
99203	Doctor's office visit, new patient (routine)	<1%	52,563	$1.54M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	6,789	$1.53M
71046	Radiologic examination, chest; 2 views	<1%	135,940	$1.45M
96161		<1%	9,331	$1.44M
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	295	$1.43M
76830	Ultrasound, transvaginal	<1%	29,480	$1.36M
52000		<1%	1,996	$1.35M
11102		<1%	3,523	$1.34M
96160		<1%	7,800	$1.31M
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	1,711	$1.30M
95813		<1%	1,962	$1.29M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	23,737	$1.28M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	7,056	$1.27M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	996	$1.25M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	8,873	$1.22M
90791	Psychiatric diagnostic evaluation	<1%	8,616	$1.21M
36415	Collection of venous blood by venipuncture	<1%	581,641	$1.20M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	289,296	$1.18M
76813		<1%	16,978	$1.14M
90834	Psychotherapy session, about 45 minutes	<1%	16,316	$1.12M
84443	Thyroid stimulating hormone (TSH)	<1%	95,475	$1.12M
J3032	Injection, eptinezumab-jjmr, 1 mg	<1%	503	$1.12M
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	145,673	$1.11M
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	20,903	$1.06M
11104		<1%	2,169	$1.05M
19318		<1%	198	$1.03M
71045	Radiologic examination, chest; single view	<1%	209,119	$1.03M
43235		<1%	2,439	$1.03M
94060		<1%	19,649	$1.03M
95782		<1%	1,666	$1.01M
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	16,244	$1.01M
J0490	Injection, belimumab, 10 mg	<1%	627	$1.01M
49083		<1%	4,673	$1000K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	920	$988K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	4,426	$986K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	7,756	$984K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	61,301	$957K
80061	Lipid panel	<1%	95,290	$955K
99204	Doctor's office visit, new patient (more involved)	<1%	19,854	$948K
31231		<1%	7,918	$946K
93325		<1%	28,217	$940K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	38,335	$937K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,394	$931K
97153	Applied behavior analysis (autism therapy), per 15 minutes	<1%	6,369	$924K
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,054	$924K
J2357	Injection, omalizumab, 5 mg	<1%	1,100	$922K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	23,442	$905K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	83,229	$903K
92551		<1%	14,442	$857K
17110		<1%	5,324	$848K
99223	Prolong inpt eval add15 m	<1%	14,496	$845K
31575		<1%	5,297	$836K
97161		<1%	17,290	$830K
31579		<1%	4,377	$822K
64643		<1%	3,871	$817K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	27,994	$805K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	1,269	$803K
83036	Hemoglobin; glycosylated (A1C)	<1%	101,129	$780K
71250		<1%	15,355	$772K
76770		<1%	6,227	$742K
80048	Basic metabolic panel (calcium, ionized)	<1%	63,647	$736K
11900		<1%	3,517	$727K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	83,006	$715K
01967	Neuraxial labor analgesia/anesthesia for planned vaginal delivery	<1%	2,516	$710K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	40,726	$710K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	7,734	$706K
97803		<1%	12,833	$705K
99479	Subsequent intensive care, per day, very low birth weight infant	<1%	8,991	$689K
90688		<1%	58,581	$674K
88307		<1%	11,172	$670K
90651		<1%	11,352	$665K
86850		<1%	24,081	$640K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	74,731	$634K
J9173	Injection, durvalumab, 10 mg	<1%	74	$625K
92557		<1%	10,251	$619K
94010		<1%	26,188	$605K
93970		<1%	10,612	$596K
70491		<1%	1,760	$587K
99460		<1%	8,181	$586K
73630		<1%	46,549	$576K
84439		<1%	34,611	$574K
97810		<1%	22,953	$574K
64483		<1%	1,509	$559K
76642		<1%	8,378	$557K
93975		<1%	4,359	$552K
90960	End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits	<1%	8,427	$550K
97535	Self-care/home management training, each 15 minutes	<1%	14,687	$547K
77300		<1%	1,032	$540K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	10,505	$538K
99238	Hospital discharge day management, 30 minutes or less	<1%	19,247	$535K
J0897	Injection, denosumab, 1 mg	<1%	1,030	$517K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,558	$509K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,458	$508K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	905	$508K
92015	Determination of refractive state	<1%	41,698	$506K
77334		<1%	1,224	$499K
85027		<1%	88,137	$498K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	740	$497K
97802		<1%	6,817	$493K
70498		<1%	1,868	$477K
93308		<1%	5,602	$474K
90837	Psychotherapy session, about an hour	<1%	3,602	$470K
96367		<1%	9,470	$467K
91200		<1%	7,454	$455K
38222		<1%	599	$452K
92567		<1%	24,357	$450K
51784		<1%	3,421	$450K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	28,079	$450K
92587		<1%	5,945	$445K
90750		<1%	2,287	$444K
99349		<1%	16,847	$439K
20611		<1%	1,458	$437K
52310		<1%	595	$437K
77301		<1%	571	$436K
J9022	Injection, atezolizumab, 10 mg	<1%	76	$429K
99308	Subsequent nursing facility care, per day, straightforward	<1%	42,862	$427K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,806	$427K
73564		<1%	35,200	$425K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	49,379	$425K
76820		<1%	6,411	$423K
87497		<1%	11,160	$422K
97113		<1%	4,960	$422K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	19,703	$416K
87481		<1%	41,287	$412K
76536		<1%	4,631	$410K
82728		<1%	29,382	$408K
90792	Psychiatric diagnostic evaluation with medical services	<1%	2,792	$408K
Q3014	Telehealth originating site facility fee	<1%	15,656	$407K
86780		<1%	28,401	$407K
93451		<1%	348	$407K
57454		<1%	1,168	$385K
82607		<1%	25,800	$378K
86803		<1%	28,432	$374K
87086	Culture, bacterial; quantitative colony count, urine	<1%	58,022	$371K
80197		<1%	24,089	$369K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	55,389	$368K
92083		<1%	12,914	$365K
93017		<1%	3,819	$353K
74018		<1%	49,827	$347K
74183		<1%	1,599	$340K
77412		<1%	1,984	$338K
99239	Hospital discharge day management, more than 30 minutes	<1%	9,896	$336K
72197		<1%	1,117	$334K
86900		<1%	24,819	$333K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	13,632	$331K
77063	Screening digital breast tomosynthesis, bilateral	<1%	7,583	$328K
J0475	Injection, baclofen, 10 mg	<1%	972	$327K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	4,036	$321K
91320		<1%	6,717	$320K
95885		<1%	1,109	$319K
86140		<1%	29,865	$317K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	29,527	$317K
64405		<1%	841	$316K
97811		<1%	22,915	$313K
93971		<1%	4,898	$309K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	14,563	$308K
19083		<1%	356	$308K
77336		<1%	2,504	$306K
58558		<1%	216	$304K
93321		<1%	4,842	$302K
84702		<1%	15,615	$302K
87340		<1%	21,651	$301K
J7300	Intrauterine copper contraceptive (paragard)	<1%	292	$301K
77295		<1%	353	$301K
76821		<1%	3,957	$299K
95117		<1%	8,959	$296K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	31,107	$293K
77371		<1%	104	$291K
73130		<1%	20,333	$289K
64493		<1%	774	$288K
J0177	Injection, aflibercept hd, 1 mg	<1%	169	$286K
93454		<1%	266	$284K
73030		<1%	22,289	$284K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	54,902	$284K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	49,823	$283K
76882		<1%	6,433	$283K
94729		<1%	16,515	$282K
73610		<1%	19,243	$278K
52287		<1%	578	$278K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	991	$278K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	3,675	$276K
77373		<1%	305	$268K
72100		<1%	14,561	$266K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,715	$265K
83540		<1%	31,567	$263K
58300		<1%	2,174	$260K
94618		<1%	5,754	$260K
20550		<1%	1,624	$258K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	7,575	$256K
96900		<1%	6,914	$248K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,554	$245K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	7,398	$243K
62323		<1%	553	$243K
11721		<1%	12,948	$243K
96416		<1%	1,690	$241K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	388	$237K
58100		<1%	1,390	$233K
73221		<1%	973	$233K
88141		<1%	11,042	$230K
92133		<1%	10,005	$230K
10005		<1%	601	$230K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	664	$229K
90715		<1%	16,997	$229K
83735		<1%	76,405	$225K
93505		<1%	198	$224K
93798		<1%	3,841	$223K
25600		<1%	725	$222K
01922		<1%	977	$221K
99243		<1%	7,058	$220K
93320		<1%	16,911	$220K
98940		<1%	8,397	$216K
83550		<1%	31,152	$213K
36430		<1%	1,533	$207K
84165		<1%	24,514	$206K
64642		<1%	4,463	$204K
10060		<1%	1,058	$203K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	10,798	$201K
77338		<1%	602	$201K
11056		<1%	2,485	$200K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	16,292	$197K
87505		<1%	1,648	$197K
76831		<1%	1,005	$195K
86334		<1%	19,958	$195K
72141		<1%	1,077	$192K
86832		<1%	5,246	$192K
97116		<1%	7,394	$191K
55700		<1%	282	$189K
86480		<1%	7,809	$189K
83970		<1%	8,299	$189K
95816		<1%	4,812	$189K
93880		<1%	2,197	$186K
73502		<1%	12,494	$185K
C1776	Joint device (implantable)	<1%	201	$184K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	1,581	$183K
97162		<1%	4,330	$182K
83655		<1%	11,207	$181K
95909		<1%	1,637	$178K
96116		<1%	768	$177K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	23,777	$177K
75561		<1%	586	$175K
99469	Subsequent inpatient neonatal critical care, per day, 28 days or younger	<1%	815	$175K
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	5,205	$174K
86901		<1%	24,760	$173K
85610		<1%	44,843	$170K
82570		<1%	25,436	$170K
92579		<1%	3,401	$169K
86762		<1%	6,862	$168K
95718		<1%	2,278	$167K
85390		<1%	8,840	$167K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	576	$166K
97165		<1%	2,581	$166K
95012		<1%	3,363	$166K
J1756	Injection, iron sucrose, 1 mg	<1%	5,692	$164K
58301		<1%	1,597	$163K
90832	Psychotherapy session, about 30 minutes	<1%	2,397	$162K
95700		<1%	1,063	$161K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	571	$160K
77470		<1%	462	$159K
J3490	Unclassified drugs	<1%	4,978	$159K
74178		<1%	577	$158K
93226		<1%	1,197	$158K
99254		<1%	2,547	$158K
90480		<1%	8,935	$157K
20526		<1%	636	$156K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	912	$156K
J7318	Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg	<1%	619	$154K
12001		<1%	809	$154K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	958	$153K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	92	$153K
Q5112	Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg	<1%	114	$152K
80069		<1%	10,535	$151K
87510		<1%	11,104	$151K
43249		<1%	377	$151K
29075		<1%	994	$150K
71271		<1%	1,321	$148K
11982		<1%	657	$148K
91120		<1%	2,468	$147K
J9306	Injection, pertuzumab, 1 mg	<1%	33	$147K
70486		<1%	1,544	$147K
99462		<1%	4,741	$147K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	2,523	$146K
0124A		<1%	5,676	$146K
90670		<1%	20,077	$146K
86706		<1%	11,164	$145K
88342		<1%	10,491	$144K
00731		<1%	8,672	$142K
11981		<1%	620	$138K
67228		<1%	420	$138K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	9,453	$136K
83880		<1%	16,125	$136K
86038		<1%	7,988	$134K
78264		<1%	646	$132K
83020		<1%	10,528	$130K
88341		<1%	2,372	$129K
95076		<1%	620	$128K
94726		<1%	3,983	$127K
80076		<1%	10,418	$126K
93922		<1%	2,600	$126K
64612		<1%	424	$124K
64616		<1%	469	$123K
20552		<1%	1,055	$123K
86833		<1%	5,335	$122K
93296		<1%	5,924	$122K
73110		<1%	7,196	$122K
J0586	Injection, abobotulinumtoxina, 5 units	<1%	174	$121K
95923		<1%	463	$119K
91010		<1%	692	$118K
77290		<1%	207	$117K
99255		<1%	1,388	$117K
91122		<1%	2,833	$115K
82784		<1%	13,780	$115K
90698		<1%	21,064	$115K
95910		<1%	1,325	$114K
78431		<1%	187	$113K
72050		<1%	3,056	$113K
81001		<1%	64,829	$113K
90636		<1%	501	$113K
87077		<1%	18,452	$113K
99222	Initial hospital care, per day, moderate complexity	<1%	3,182	$112K
77049		<1%	291	$111K
96156		<1%	695	$110K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	130	$110K
95924		<1%	464	$109K
69210		<1%	4,647	$109K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	3,204	$109K
98941	Chiropractic manipulative treatment; spinal, 3-4 regions	<1%	3,860	$108K
90472	Immunization administration, each additional vaccine (list separately)	<1%	42,502	$108K
88112		<1%	7,673	$107K
20600		<1%	629	$107K
90620		<1%	2,699	$107K
90945		<1%	3,258	$107K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,261	$106K
90619		<1%	6,896	$105K
84484		<1%	36,756	$105K
17000		<1%	956	$104K
86704		<1%	8,426	$104K
92235		<1%	830	$103K
95819		<1%	1,259	$103K
H1000	Prenatal care, at-risk assessment	<1%	794	$103K
70544		<1%	558	$102K
92136		<1%	4,192	$102K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	6,015	$102K
J2777	Injection, faricimab-svoa, 0.1 mg	<1%	98	$101K
99205	Prolong outpt/office vis	<1%	2,104	$101K
30140		<1%	80	$101K
86077		<1%	3,460	$100K
70496		<1%	2,187	$100K
93016		<1%	7,008	$100K
84100		<1%	27,055	$98K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	73	$97K
87799		<1%	6,997	$97K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	8,198	$97K
99480	Subsequent intensive care, per day, low birth weight infant	<1%	1,323	$97K
99442		<1%	5,986	$96K
0002A		<1%	2,702	$96K
J3111	Injection, romosozumab-aqqg, 1 mg	<1%	97	$95K
20605		<1%	539	$95K
26600		<1%	261	$94K
26720		<1%	276	$94K
88184		<1%	1,208	$94K
81455		<1%	268	$93K
93225		<1%	1,358	$93K
84403		<1%	6,774	$93K
82977		<1%	9,227	$93K
76512		<1%	997	$93K
77080		<1%	1,840	$92K
72156		<1%	967	$91K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	752	$91K
66821		<1%	429	$90K
99472	Subsequent inpatient pediatric critical care, per day, 2-5 years	<1%	415	$90K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	450	$90K
17250		<1%	413	$89K
J9070	Cyclophosphamide, 100 mg	<1%	701	$89K
77062		<1%	2,078	$88K
J9041	Injection, bortezomib, 0.1 mg	<1%	2,209	$87K
84153		<1%	7,967	$87K
50200		<1%	228	$87K
97804		<1%	4,027	$86K
87522	Neg quan hep c or qual rna	<1%	4,449	$86K
70546		<1%	447	$86K
0001A		<1%	2,924	$85K
31237		<1%	163	$85K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	37,145	$85K
87660		<1%	11,366	$84K
12011		<1%	444	$84K
94621		<1%	767	$84K
99497		<1%	1,381	$84K
76881		<1%	857	$84K
99217		<1%	3,467	$84K
87653		<1%	5,108	$83K
82670		<1%	4,028	$83K
11055		<1%	761	$81K
17311		<1%	222	$81K
64721		<1%	91	$81K
74230		<1%	522	$81K
97164		<1%	1,086	$81K
20553		<1%	790	$81K
99152		<1%	7,050	$80K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	759	$80K
97166		<1%	1,332	$80K
74174		<1%	1,049	$80K
99306	Prolong nursin fac eval 15m	<1%	3,096	$79K
97155	Adaptive behavior treatment with protocol modification, administered by physician, each 15 minutes	<1%	964	$79K
84481		<1%	8,016	$79K
90658		<1%	8,433	$79K
73700		<1%	591	$79K
82533		<1%	3,236	$78K
94642		<1%	699	$78K
88304		<1%	9,792	$78K
90633		<1%	10,188	$78K
73560		<1%	4,346	$76K
76825		<1%	642	$75K
93246		<1%	1,943	$75K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,057	$74K
00104		<1%	1,963	$73K
99253		<1%	1,804	$73K
81370		<1%	616	$73K
85652		<1%	23,769	$71K
64450		<1%	446	$71K
82043		<1%	15,175	$71K
11983		<1%	183	$71K
93799		<1%	8,383	$71K
77061		<1%	1,567	$70K
99245		<1%	974	$70K
74160		<1%	435	$70K
90716		<1%	4,821	$68K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	272	$68K
82805		<1%	2,671	$68K
84146		<1%	4,240	$67K
99397		<1%	738	$67K
78816		<1%	75	$66K
96130		<1%	1,579	$66K
C9257	Injection, bevacizumab, 0.25 mg	<1%	2,439	$66K
94660		<1%	778	$66K
00811		<1%	4,389	$66K
95911		<1%	730	$65K
99406		<1%	2,582	$65K
00142		<1%	4,853	$65K
88346		<1%	1,412	$65K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	238	$64K
86258		<1%	3,478	$64K
99350	Prolong home eval add 15m	<1%	1,688	$64K
87493		<1%	1,859	$64K
29405		<1%	421	$63K
73140		<1%	3,127	$63K
98927		<1%	2,111	$63K
58340		<1%	1,022	$62K
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	5,306	$62K
93990		<1%	1,594	$61K
86364		<1%	4,893	$61K
83001		<1%	4,441	$61K
77014		<1%	2,286	$61K
51728		<1%	311	$60K
72131		<1%	746	$60K
36514		<1%	67	$60K
74240		<1%	335	$59K
36589		<1%	186	$59K
90686		<1%	8,239	$59K
72158		<1%	408	$58K
74019		<1%	1,621	$58K
85396		<1%	5,469	$58K
72110		<1%	1,640	$58K
99443		<1%	2,787	$57K
88185		<1%	1,208	$57K
31624		<1%	125	$57K
93923		<1%	1,082	$57K
86003		<1%	3,528	$56K
82627		<1%	2,861	$55K
51798		<1%	7,898	$55K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	1,878	$54K
85060		<1%	4,840	$54K
93660		<1%	495	$54K
82746		<1%	9,420	$54K
82962		<1%	34,773	$53K
81003		<1%	61,868	$53K
81206		<1%	347	$53K
77065	Tomosynthesis, mammo	<1%	3,207	$53K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,626	$52K
45381		<1%	78	$52K
82950		<1%	4,434	$52K
76857		<1%	2,197	$52K
82105		<1%	4,066	$51K
90870		<1%	1,760	$51K
99358	Prolong nursin fac eval 15m	<1%	338	$51K
J9312	Injection, rituximab, 10 mg	<1%	25	$51K
70552		<1%	350	$51K
90839		<1%	552	$50K
86147		<1%	1,889	$50K
81025		<1%	46,312	$50K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	<1%	43	$49K
72040		<1%	1,461	$49K
43248		<1%	141	$49K
86431		<1%	5,057	$49K
86376		<1%	3,206	$49K
87186		<1%	14,116	$49K
73562		<1%	1,541	$48K
45330		<1%	103	$48K
86160		<1%	4,426	$48K
95992		<1%	570	$48K
11750		<1%	121	$48K
90680		<1%	12,730	$48K
86359		<1%	2,360	$47K
70543		<1%	131	$47K
28470		<1%	152	$47K
96523		<1%	1,049	$46K
86235		<1%	4,370	$46K
92025		<1%	1,032	$46K
92524		<1%	573	$46K
95115		<1%	1,320	$46K
90746		<1%	2,615	$46K
62369		<1%	1,742	$45K
85018		<1%	8,466	$45K
54161		<1%	32	$45K
77066	Tomosynthesis, mammo	<1%	2,616	$45K
73590		<1%	2,292	$45K
51705		<1%	870	$44K
76514		<1%	1,097	$44K
J2791	Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu	<1%	699	$44K
87536		<1%	1,937	$44K
91112		<1%	255	$44K
92250		<1%	1,283	$44K
84402		<1%	2,850	$43K
87070		<1%	7,734	$43K
98926		<1%	1,394	$43K
83615		<1%	9,528	$43K
93018		<1%	5,049	$43K
78306		<1%	332	$42K
99153	Mod sedat endo service >5yrs	<1%	5,090	$42K
77370		<1%	532	$42K
82525		<1%	3,488	$42K
11100		<1%	209	$41K
90697		<1%	4,981	$41K
82024		<1%	1,404	$41K
43762		<1%	255	$41K
70480		<1%	261	$41K
87640		<1%	1,965	$41K
72082		<1%	1,320	$41K
68840		<1%	103	$40K
72157		<1%	528	$40K
96375	Therapeutic injection; each additional sequential IV push	<1%	36,903	$40K
88360		<1%	804	$40K
76827		<1%	642	$39K
73070		<1%	1,241	$39K
92611		<1%	527	$39K
84630		<1%	3,974	$39K
19081		<1%	41	$39K
86225		<1%	4,474	$39K
84156		<1%	11,919	$39K
96368		<1%	2,129	$39K
41899	Unlisted procedure, dentoalveolar structures	<1%	56	$39K
85576		<1%	1,626	$38K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	2,067	$38K
99221		<1%	1,487	$38K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	573	$38K
93926		<1%	656	$37K
80502		<1%	1,338	$37K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	100	$37K
27447		<1%	37	$37K
88365		<1%	377	$36K
86335		<1%	2,688	$36K
90739		<1%	2,150	$36K
88313		<1%	4,940	$36K
81240		<1%	435	$36K
86200		<1%	3,555	$36K
83525		<1%	1,858	$36K
81382		<1%	309	$35K
90744		<1%	7,411	$35K
51741		<1%	649	$35K
92582		<1%	506	$35K
73718		<1%	134	$35K
93978		<1%	314	$35K
90696		<1%	4,867	$34K
73523		<1%	1,413	$34K
72072		<1%	1,194	$34K
83002		<1%	2,909	$34K
88264		<1%	263	$34K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	170	$34K
86256		<1%	3,483	$34K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	3,488	$34K
73080		<1%	1,955	$34K
72146		<1%	325	$34K
81256		<1%	290	$34K
92526		<1%	578	$34K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	632	$34K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,651	$33K
C1874	Stent, coated/covered, with delivery system	<1%	144	$33K
82550		<1%	8,423	$33K
84166		<1%	3,522	$33K
31628		<1%	102	$33K
85240		<1%	937	$32K
82947		<1%	4,678	$32K
84480		<1%	3,269	$32K
86800		<1%	2,517	$32K
83520		<1%	2,353	$31K
73090		<1%	1,553	$31K
97163		<1%	643	$31K
83993		<1%	1,558	$31K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,397	$31K
J2997	Injection, alteplase recombinant, 1 mg	<1%	146	$31K
96146		<1%	287	$31K
99417	Prolong home eval add 15m	<1%	441	$30K
96101		<1%	627	$30K
92340	Fitting of spectacles, except for aphakia; monofocal	<1%	1,796	$30K
83521		<1%	4,770	$30K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,356	$30K
84550		<1%	6,437	$30K
90662		<1%	5,220	$30K
62328		<1%	47	$29K
87641		<1%	1,974	$29K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	218	$29K
92553		<1%	371	$29K
87902		<1%	183	$29K
J9035	Injection, bevacizumab, 10 mg	<1%	105	$29K
95024		<1%	685	$29K
88311		<1%	4,685	$28K
82785		<1%	2,686	$28K
86923		<1%	978	$28K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	270	$28K
36591		<1%	1,491	$28K
88172		<1%	348	$28K
88350		<1%	893	$28K
99385		<1%	552	$27K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	21,265	$27K
86870		<1%	797	$27K
55250		<1%	20	$27K
76818		<1%	239	$27K
87517		<1%	958	$27K
82330		<1%	3,971	$27K
77427		<1%	288	$27K
93312		<1%	158	$27K
83690		<1%	19,746	$27K
99464		<1%	386	$27K
12002		<1%	160	$27K
87529		<1%	2,237	$27K
84425		<1%	3,064	$26K
76937		<1%	1,308	$26K
11103		<1%	528	$26K
90461		<1%	19,581	$26K
64415		<1%	49	$26K
85730		<1%	11,269	$26K
87480		<1%	11,110	$25K
87205		<1%	7,280	$25K
27786		<1%	80	$25K
64644		<1%	576	$25K
73100		<1%	567	$25K
29065		<1%	153	$25K
72070		<1%	820	$25K
83516		<1%	1,849	$25K
82565		<1%	4,138	$25K
93298		<1%	1,218	$25K
80074		<1%	2,700	$25K
76870		<1%	925	$24K
93750		<1%	2,012	$24K
74270		<1%	173	$24K
82951		<1%	937	$24K
96401		<1%	2,782	$24K
86787		<1%	2,185	$24K
52356		<1%	16	$23K
77072		<1%	543	$23K
15275		<1%	105	$23K
82103		<1%	2,357	$23K
84207		<1%	2,355	$23K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	885	$23K
85597		<1%	888	$23K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	297	$23K
95912		<1%	357	$22K
J9074	Injection, cyclophosphamide (sandoz), 5 mg	<1%	69	$22K
92541		<1%	417	$22K
84460		<1%	3,993	$22K
81596		<1%	308	$22K
66982		<1%	34	$22K
82610		<1%	1,744	$22K
84432		<1%	996	$22K
86304		<1%	1,512	$22K
86141		<1%	1,198	$22K
84144		<1%	1,119	$22K
99441		<1%	2,572	$22K
31615		<1%	26	$22K
29515		<1%	466	$21K
86708		<1%	2,112	$21K
95251		<1%	1,373	$21K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	5,148	$21K
11440		<1%	53	$21K
90710		<1%	5,038	$21K
84155		<1%	5,391	$21K
99220		<1%	394	$21K
78582		<1%	32	$21K
90961		<1%	544	$21K
74021		<1%	549	$21K
77280		<1%	154	$21K
82088		<1%	934	$21K
84450		<1%	3,309	$20K
G0179	Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care	<1%	3,283	$20K
90707		<1%	5,056	$20K
73552		<1%	1,204	$20K
99219		<1%	366	$20K
93925		<1%	162	$20K
86361		<1%	1,511	$20K
91065		<1%	522	$20K
86355		<1%	2,293	$20K
86920		<1%	592	$20K
10061		<1%	101	$19K
86015		<1%	952	$19K
96112		<1%	149	$19K
97813		<1%	755	$19K
11200		<1%	100	$19K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	1,554	$19K
86765		<1%	1,900	$19K
36573		<1%	15	$19K
88237		<1%	353	$19K
72200		<1%	589	$19K
96376		<1%	6,472	$19K
86039		<1%	2,010	$19K
82248		<1%	2,561	$18K
92652		<1%	398	$18K
82274		<1%	890	$18K
75574		<1%	86	$18K
71101		<1%	1,076	$18K
G0425	Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth	<1%	336	$18K
80324		<1%	1,871	$18K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	161	$18K
87328		<1%	828	$18K
82378		<1%	2,037	$18K
87338		<1%	854	$18K
92555		<1%	492	$18K
86735		<1%	1,079	$18K
99252		<1%	563	$18K
84445		<1%	877	$18K
86665		<1%	1,697	$18K
59409	Vaginal delivery only (with or without episiotomy and/or forceps)	<1%	28	$17K
86308		<1%	1,144	$17K
0004A		<1%	519	$17K
85045		<1%	6,168	$17K
70355		<1%	488	$17K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,935	$17K
52332		<1%	15	$17K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	127	$17K
86580		<1%	563	$16K
86317		<1%	1,448	$16K
69209		<1%	2,155	$16K
95874		<1%	6,513	$16K
86146		<1%	1,375	$16K
86695		<1%	1,712	$16K
30520		<1%	18	$16K
83498		<1%	1,162	$16K
76775		<1%	123	$16K
83921		<1%	2,172	$16K
82542		<1%	1,279	$16K
80164		<1%	1,312	$15K
0081A		<1%	563	$15K
46221		<1%	29	$15K
78830		<1%	29	$15K
J9075	Injection, cyclophosphamide, not otherwise specified, 5 mg	<1%	93	$15K
92700		<1%	316	$15K
J9171	Injection, docetaxel, 1 mg	<1%	238	$15K
84305		<1%	863	$15K
72170		<1%	917	$15K
62321		<1%	27	$15K
73000		<1%	391	$15K
11402		<1%	26	$15K
73200		<1%	96	$15K
86644		<1%	1,062	$14K
95044		<1%	40	$14K
62370		<1%	293	$14K
73060		<1%	846	$14K
46600		<1%	1,235	$14K
17003		<1%	531	$14K
86301		<1%	1,186	$14K
54150		<1%	369	$14K
11720		<1%	408	$14K
0054A		<1%	787	$14K
73660		<1%	767	$14K
86036		<1%	1,012	$14K
99471		<1%	26	$14K
99386		<1%	240	$14K
80175		<1%	910	$13K
51720		<1%	50	$13K
J3489	Injection, zoledronic acid, 1 mg	<1%	816	$13K
86696		<1%	1,697	$13K
92556		<1%	335	$13K
96131		<1%	365	$13K
00300		<1%	724	$13K
0154A		<1%	350	$13K
84681		<1%	1,089	$13K
G0426	Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth	<1%	179	$13K
57456		<1%	33	$13K
84244		<1%	876	$13K
77085		<1%	277	$13K
86341		<1%	977	$13K
80177		<1%	1,406	$13K
71555		<1%	81	$13K
82952		<1%	782	$13K
94799		<1%	694	$13K
99348		<1%	644	$13K
81332		<1%	389	$13K
77387		<1%	248	$13K
82390		<1%	1,306	$13K
99242		<1%	527	$12K
72128		<1%	262	$12K
92546		<1%	154	$12K
92552		<1%	187	$12K
84154		<1%	1,326	$12K
0071A		<1%	422	$12K
23500		<1%	34	$12K
93295		<1%	434	$12K
00840		<1%	725	$12K
51700		<1%	224	$12K
82040		<1%	1,823	$12K
93351		<1%	712	$11K
83010		<1%	1,498	$11K
J9206	Injection, irinotecan, 20 mg	<1%	1,040	$11K
43237		<1%	29	$11K
0402T		<1%	16	$11K
97814		<1%	754	$11K
80158		<1%	741	$11K
J2704	Injection, propofol, 10 mg	<1%	33,447	$11K
80323		<1%	1,327	$11K
84163		<1%	418	$11K
82653		<1%	515	$11K
82150		<1%	2,496	$11K
84270		<1%	709	$11K
86381		<1%	873	$11K
95018		<1%	347	$11K
85041		<1%	2,301	$11K
J9395	Injection, fulvestrant, 25 mg	<1%	99	$10K
J9323	Injection, pemetrexed ditromethamine, 10 mg	<1%	93	$10K
0082A		<1%	343	$10K
J9045	Injection, carboplatin, 50 mg	<1%	1,356	$10K
00140		<1%	815	$10K
92523		<1%	294	$10K
81268		<1%	45	$10K
88312		<1%	991	$10K
80348		<1%	1,902	$10K
84436		<1%	936	$10K
82397		<1%	796	$10K
80361		<1%	1,870	$10K
80365		<1%	1,969	$10K
86255		<1%	1,325	$10K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	815	$10K
76942		<1%	1,732	$10K
80373		<1%	1,870	$10K
90474		<1%	2,234	$10K
92626		<1%	135	$10K
51600		<1%	209	$10K
92550		<1%	228	$10K
90632		<1%	459	$10K
83605		<1%	7,688	$10K
93985		<1%	142	$10K
27130		<1%	13	$9K
96402		<1%	1,255	$9K
86705		<1%	693	$9K
83721		<1%	1,645	$9K
86618		<1%	879	$9K
86664		<1%	667	$9K
85379		<1%	5,059	$9K
80354		<1%	1,870	$9K
80349		<1%	1,870	$9K
84132		<1%	3,773	$9K
70487		<1%	29	$9K
90785		<1%	978	$9K
75565		<1%	645	$9K
51797		<1%	498	$9K
86300		<1%	531	$9K
00813		<1%	2,692	$9K
64447		<1%	54	$9K
J3470	Injection, hyaluronidase, up to 150 units	<1%	684	$9K
87040		<1%	4,636	$9K
80356		<1%	1,858	$9K
92545		<1%	276	$9K
80353		<1%	1,871	$9K
86880		<1%	515	$9K
82085		<1%	897	$9K
87329		<1%	822	$9K
86922		<1%	424	$8K
92285		<1%	203	$8K
90685		<1%	1,569	$8K
80178		<1%	567	$8K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	961	$8K
00145		<1%	523	$8K
36471		<1%	12	$8K
80364		<1%	1,870	$8K
80358		<1%	1,871	$8K
86592		<1%	1,574	$8K
0072A		<1%	277	$8K
00520		<1%	887	$8K
11980		<1%	26	$8K
77075		<1%	78	$8K
87177		<1%	374	$8K
92060		<1%	661	$8K
96132		<1%	779	$8K
82652		<1%	899	$8K
84590		<1%	1,169	$8K
82164		<1%	692	$8K
G0452	Molecular pathology procedure; physician interpretation and report	<1%	909	$8K
76883		<1%	59	$8K
82310		<1%	956	$8K
47000		<1%	18	$8K
92519		<1%	37	$8K
83835		<1%	527	$8K
87015		<1%	1,318	$8K
82232		<1%	666	$8K
93000		<1%	521	$8K
96152		<1%	214	$8K
A9270	Non-covered item or service	<1%	8,875	$8K
96158		<1%	300	$8K
83695		<1%	861	$8K
82677		<1%	237	$8K
64494		<1%	688	$8K
70250		<1%	244	$8K
92542		<1%	317	$8K
97597		<1%	189	$8K
96136		<1%	883	$7K
86921		<1%	389	$7K
86357		<1%	807	$7K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	59	$7K
99383		<1%	145	$7K
74220		<1%	168	$7K
72220		<1%	347	$7K
84134		<1%	769	$7K
29125		<1%	429	$7K
80299		<1%	431	$7K
51702		<1%	573	$7K
J1815	Injection, insulin, per 5 units	<1%	678	$7K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	288	$7K
86360		<1%	788	$7K
87102		<1%	1,762	$7K
0298T		<1%	117	$7K
36226		<1%	15	$7K
93976		<1%	55	$7K
20551		<1%	32	$7K
99305		<1%	347	$7K
99201		<1%	692	$7K
82077		<1%	4,612	$7K
85520		<1%	1,333	$7K
77293		<1%	53	$7K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	2,496	$7K
0051A		<1%	282	$7K
C1760	Closure device, vascular (implantable/insertable)	<1%	612	$7K
76604		<1%	94	$6K
83519		<1%	609	$6K
88142		<1%	1,234	$6K
87088		<1%	1,871	$6K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	495	$6K
90966		<1%	65	$6K
93248		<1%	363	$6K
12032		<1%	307	$6K
87563		<1%	479	$6K
88173		<1%	1,206	$6K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	14	$6K
99421		<1%	684	$6K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	20,076	$6K
73522		<1%	153	$6K
81479	Unlisted molecular pathology procedure	<1%	89	$6K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	23,708	$6K
84466		<1%	880	$6K
82340		<1%	531	$6K
89051		<1%	2,339	$6K
80235		<1%	623	$6K
92082		<1%	123	$6K
77091		<1%	276	$6K
88291		<1%	695	$6K
80143		<1%	1,036	$6K
84446		<1%	890	$6K
90648		<1%	930	$5K
94681		<1%	147	$5K
82180		<1%	567	$5K
00790		<1%	363	$5K
64999		<1%	44	$5K
83090		<1%	1,113	$5K
74221		<1%	31	$5K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	28	$5K
90678		<1%	755	$5K
82175		<1%	388	$5K
84080		<1%	720	$5K
99307		<1%	695	$5K
36600		<1%	808	$5K
85014		<1%	999	$5K
28490		<1%	13	$5K
80203		<1%	579	$5K
82668		<1%	448	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	152	$5K
80346		<1%	579	$5K
00400		<1%	970	$5K
93280		<1%	617	$5K
J7325	Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg	<1%	25	$5K
80321		<1%	642	$5K
85384		<1%	1,324	$5K
0052A		<1%	211	$5K
81374		<1%	31	$5K
26750		<1%	14	$5K
93284		<1%	362	$5K
82247		<1%	1,192	$5K
73521		<1%	152	$5K
82140		<1%	629	$5K
97032		<1%	353	$5K
94664		<1%	474	$5K
86593		<1%	535	$5K
88331		<1%	82	$5K
30901		<1%	114	$4K
80047		<1%	593	$4K
70360		<1%	282	$4K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	7,381	$4K
80183		<1%	420	$4K
86703		<1%	2,365	$4K
90681		<1%	578	$4K
C1883	Adapter/extension, pacing lead or neurostimulator lead (implantable)	<1%	64	$4K
85613		<1%	1,483	$4K
93356		<1%	566	$4K
73650		<1%	133	$4K
90700		<1%	780	$4K
83013		<1%	80	$4K
93299		<1%	158	$4K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,046	$4K
01961		<1%	13	$4K
95712		<1%	42	$4K
87206		<1%	1,354	$4K
75635		<1%	12	$4K
97750		<1%	45	$4K
G0008	Administration of influenza virus vaccine	<1%	6,509	$4K
85598		<1%	624	$4K
90732		<1%	359	$4K
88300		<1%	1,432	$4K
82495		<1%	340	$4K
74712		<1%	17	$4K
86677		<1%	494	$4K
84238		<1%	233	$4K
86709		<1%	547	$4K
00120		<1%	203	$4K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	513	$4K
84703		<1%	3,438	$4K
69200		<1%	210	$4K
64495		<1%	261	$4K
93793		<1%	1,040	$4K
80201		<1%	277	$4K
87209		<1%	350	$4K
84075		<1%	832	$4K
82787		<1%	437	$4K
98928		<1%	163	$4K
85670		<1%	1,193	$4K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	336	$4K
92597		<1%	72	$4K
83825		<1%	516	$4K
77002		<1%	320	$4K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,166	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,072	$4K
87116		<1%	1,050	$4K
99195		<1%	112	$3K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	438	$3K
86828		<1%	520	$3K
82523		<1%	374	$3K
J1644	Injection, heparin sodium, per 1000 units	<1%	8,988	$3K
86682		<1%	370	$3K
11901		<1%	14	$3K
99173		<1%	1,499	$3K
00160		<1%	531	$3K
87507		<1%	97	$3K
90734		<1%	553	$3K
77074		<1%	147	$3K
92341		<1%	173	$3K
0003A		<1%	87	$3K
99236	Prolong inpt eval add15 m	<1%	53	$3K
92504		<1%	2,342	$3K
96137		<1%	238	$3K
36592		<1%	150	$3K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	29	$3K
96118		<1%	22	$3K
29425		<1%	15	$3K
76377		<1%	2,296	$3K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	410	$3K
11730		<1%	32	$3K
93227		<1%	142	$3K
87101		<1%	488	$3K
82803		<1%	1,803	$3K
83630		<1%	142	$3K
82375		<1%	1,692	$3K
93458		<1%	29	$3K
90656		<1%	362	$3K
95079		<1%	15	$3K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,558	$3K
98929		<1%	55	$3K
92020		<1%	424	$3K
80179		<1%	945	$3K
77077		<1%	141	$3K
86008		<1%	411	$3K
81002		<1%	4,065	$3K
92604		<1%	176	$3K
J1611	Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg	<1%	69	$3K
92242		<1%	12	$3K
82010		<1%	1,323	$3K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	24,207	$3K
77073		<1%	123	$3K
76506		<1%	94	$3K
74150		<1%	17	$2K
12031		<1%	41	$2K
84145		<1%	687	$2K
00812		<1%	969	$2K
95908		<1%	14	$2K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,371	$2K
90962		<1%	87	$2K
87486		<1%	277	$2K
93283		<1%	265	$2K
84478		<1%	369	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	30,061	$2K
D1208	Topical application of fluoride, excluding varnish	<1%	164	$2K
C1781	Mesh (implantable)	<1%	93	$2K
J0485	Injection, belatacept, 1 mg	<1%	26	$2K
85046		<1%	383	$2K
93319		<1%	47	$2K
90714		<1%	158	$2K
93282		<1%	159	$2K
C1889	Implantable/insertable device, not otherwise classified	<1%	781	$2K
97129		<1%	88	$2K
82530		<1%	105	$2K
86777		<1%	152	$2K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	3,160	$2K
94070		<1%	13	$2K
96111		<1%	64	$2K
84300		<1%	517	$2K
82166		<1%	127	$2K
88189		<1%	53	$2K
96417		<1%	3,925	$2K
92132		<1%	98	$2K
83785		<1%	291	$2K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	685	$2K
74022		<1%	331	$2K
00320		<1%	469	$2K
83021		<1%	164	$2K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	21	$2K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	2,181	$2K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	28,225	$2K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,282	$2K
82365		<1%	303	$2K
J2800	Injection, methocarbamol, up to 10 ml	<1%	717	$2K
C9113	Injection, pantoprazole sodium, per vial	<1%	1,050	$2K
92610		<1%	46	$2K
85732		<1%	468	$2K
88302		<1%	207	$2K
85307		<1%	276	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	33,834	$2K
73600		<1%	68	$2K
87900		<1%	16	$2K
85097		<1%	57	$2K
88271		<1%	20	$2K
88177		<1%	472	$2K
84182		<1%	123	$2K
80320		<1%	279	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,590	$2K
84252		<1%	229	$2K
99384		<1%	24	$2K
96150		<1%	32	$2K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	5,801	$2K
80500		<1%	276	$2K
83883		<1%	134	$2K
82384		<1%	55	$2K
90713		<1%	337	$2K
87581		<1%	289	$2K
84295		<1%	1,892	$2K
84520		<1%	693	$2K
77263		<1%	25	$2K
82671		<1%	114	$2K
82553		<1%	240	$2K
00902		<1%	387	$2K
72052		<1%	27	$1K
99292		<1%	32	$1K
94760		<1%	12,322	$1K
0083A		<1%	87	$1K
99495		<1%	391	$1K
87081		<1%	232	$1K
77001		<1%	229	$1K
82379		<1%	256	$1K
36620		<1%	258	$1K
81329		<1%	15	$1K
83789		<1%	142	$1K
96409		<1%	498	$1K
82104		<1%	203	$1K
00537		<1%	45	$1K
96133		<1%	711	$1K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,241	$1K
J3535	Drug administered through a metered dose inhaler	<1%	95	$1K
00910		<1%	334	$1K
82139		<1%	135	$1K
V2020	Frames, purchases	<1%	150	$1K
01810		<1%	334	$1K
86336		<1%	229	$1K
36556		<1%	101	$1K
82955		<1%	105	$1K
85245		<1%	57	$1K
J1071	Injection, testosterone cypionate, 1 mg	<1%	416	$1K
01920		<1%	21	$1K
J0690	Injection, cefazolin sodium, 500 mg	<1%	9,912	$1K
87109		<1%	226	$1K
87210		<1%	517	$1K
01480		<1%	162	$1K
85246		<1%	61	$1K
00940		<1%	121	$1K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	3,591	$1K
99218		<1%	33	$1K
99459		<1%	32	$1K
11105		<1%	928	$1K
83050		<1%	1,765	$1K
01844		<1%	38	$1K
94761		<1%	1,332	$1K
85660		<1%	293	$1K
88377		<1%	82	$1K
51701		<1%	101	$1K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	9,289	$1K
84433		<1%	157	$992.29
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,168	$992.18
92002		<1%	31	$987.69
80165		<1%	118	$979.40
85300		<1%	302	$957.50
86825		<1%	13	$928.17
99483	Prolong outpt/office vis	<1%	59	$926.79
86053		<1%	88	$917.21
82747		<1%	124	$914.61
97763		<1%	13	$898.85
99310	Prolong nursin fac eval 15m	<1%	37	$894.45
88344		<1%	15	$887.30
00920		<1%	466	$880.11
J7050	Infusion, normal saline solution, 250 cc	<1%	17,320	$878.87
84479		<1%	158	$877.09
80195		<1%	105	$869.50
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	37,510	$849.50
J2785	Injection, regadenoson, 0.1 mg	<1%	1,848	$836.23
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	630	$829.82
87324		<1%	71	$822.27
78492		<1%	16	$820.40
J7030	Infusion, normal saline solution , 1000 cc	<1%	17,375	$806.20
96103		<1%	101	$805.87
96153		<1%	79	$797.84
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	66	$794.20
99225		<1%	60	$793.95
98968		<1%	209	$787.81
87220		<1%	275	$783.35
J3370	Injection, vancomycin hcl, 500 mg	<1%	3,244	$775.72
11719		<1%	47	$755.18
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,131	$751.41
80377		<1%	30	$747.65
86041		<1%	134	$746.15
96139		<1%	737	$743.62
85303		<1%	281	$738.21
87075		<1%	630	$737.29
85306		<1%	263	$725.27
87106		<1%	226	$723.76
83935		<1%	151	$717.80
V2100	Sphere, single vision, plano to plus or minus 4.00, per lens	<1%	69	$711.61
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	622	$699.53
59430		<1%	13	$696.28
G0475	Hiv antigen/antibody, combination assay, screening	<1%	812	$688.25
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	809	$680.99
C1769	Guide wire	<1%	3,222	$680.53
88720		<1%	3,035	$659.69
80230		<1%	130	$652.49
36416		<1%	5,320	$638.26
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	2,162	$637.14
86316		<1%	64	$630.31
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	29,252	$627.45
93244		<1%	38	$627.03
74328		<1%	25	$624.52
89060		<1%	345	$597.95
76376		<1%	173	$596.03
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	1,136	$591.83
99241		<1%	43	$589.10
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,763	$588.63
76098		<1%	15	$583.88
99226		<1%	17	$556.05
86363		<1%	92	$555.29
80185		<1%	73	$550.26
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,362	$543.39
00126		<1%	704	$542.39
83930		<1%	145	$540.08
0064A		<1%	19	$539.52
64646		<1%	27	$532.99
86808		<1%	38	$514.34
96910		<1%	18	$495.06
86645		<1%	36	$492.80
87305		<1%	91	$492.38
0399T		<1%	15	$489.81
90723		<1%	181	$488.50
84210		<1%	95	$487.39
V2784	Lens, polycarbonate or equal, any index, per lens	<1%	165	$481.15
83986		<1%	144	$478.67
86060		<1%	22	$476.16
J0461	Injection, atropine sulfate, 0.01 mg	<1%	390	$474.57
J3475	Injection, magnesium sulfate, per 500 mg	<1%	7,148	$472.94
87341		<1%	75	$468.77
C1830	Powered bone marrow biopsy needle	<1%	518	$467.58
99345	Prolong home eval add 15m	<1%	13	$464.76
87176		<1%	463	$460.60
G0444	Annual depression screening, 5 to 15 minutes	<1%	1,004	$454.48
99354		<1%	14	$453.16
83918		<1%	49	$452.58
93042		<1%	251	$437.78
01470		<1%	19	$435.37
86753		<1%	43	$431.45
00732		<1%	112	$428.85
J0834	Injection, cosyntropin, 0.25 mg	<1%	19	$425.92
J9181	Injection, etoposide, 10 mg	<1%	95	$417.42
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,304	$415.49
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,388	$408.73
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,833	$401.70
85049		<1%	173	$398.16
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	25	$397.25
96377		<1%	698	$395.31
80162		<1%	37	$389.86
90846	Family psychotherapy without the patient present, 50 minutes	<1%	12	$384.40
G0009	Administration of pneumococcal vaccine	<1%	1,845	$384.32
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,268	$381.82
96138		<1%	737	$378.73
86687		<1%	38	$369.76
82945		<1%	516	$365.26
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,550	$359.05
83014		<1%	25	$356.52
G0180	Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care	<1%	103	$356.07
80169		<1%	15	$356.06
87154		<1%	12	$355.98
01830		<1%	170	$351.00
62252		<1%	63	$349.87
95822		<1%	33	$343.61
82172		<1%	14	$336.42
29130		<1%	14	$334.32
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	1,103	$332.46
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	579	$329.43
87184		<1%	192	$322.73
J1940	Injection, furosemide, up to 20 mg	<1%	2,136	$322.24
36410		<1%	82	$321.99
99496		<1%	129	$321.36
0031A		<1%	13	$315.13
92226		<1%	27	$303.81
93261		<1%	15	$303.51
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	518	$298.51
84255		<1%	59	$294.87
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	199	$289.30
84157		<1%	654	$284.84
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	169	$283.58
87147		<1%	126	$275.30
86606		<1%	31	$274.53
95249		<1%	32	$272.48
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	515	$269.39
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,341	$268.54
85247		<1%	24	$262.35
A4648	Tissue marker, implantable, any type, each	<1%	801	$261.27
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	5,547	$259.42
93294		<1%	25	$259.07
73620		<1%	52	$252.16
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,007	$248.32
J3360	Injection, diazepam, up to 5 mg	<1%	433	$246.98
J1790	Injection, droperidol, up to 5 mg	<1%	2,949	$238.72
77081		<1%	16	$235.40
99251		<1%	12	$231.10
93228		<1%	12	$228.75
86596		<1%	54	$227.86
J2720	Injection, protamine sulfate, per 10 mg	<1%	379	$226.84
J1953	Injection, levetiracetam, 10 mg	<1%	75	$221.46
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	925	$213.54
82272		<1%	30	$203.75
90647		<1%	18	$200.05
92650		<1%	16	$197.38
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	40	$197.09
J9370	Vincristine sulfate, 1 mg	<1%	313	$197.04
80156		<1%	13	$196.83
J2060	Injection, lorazepam, 2 mg	<1%	1,708	$193.55
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	1,738	$184.24
99327		<1%	13	$176.98
96040		<1%	13	$176.40
C1726	Catheter, balloon dilatation, non-vascular	<1%	974	$172.78
93041		<1%	131	$172.58
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	755	$171.03
87899		<1%	95	$170.25
J3480	Injection, potassium chloride, per 2 meq	<1%	2,592	$169.20
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	1,614	$160.86
96411		<1%	1,139	$150.08
86698		<1%	18	$146.31
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	5,262	$144.24
J3590	Unclassified biologics	<1%	15	$144.06
86635		<1%	17	$141.09
86612		<1%	19	$134.65
86001		<1%	25	$133.67
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,254	$125.13
00952		<1%	138	$124.50
90672		<1%	12	$123.50
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	3,864	$122.66
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	651	$119.38
C1729	Catheter, drainage	<1%	409	$118.35
87255		<1%	12	$111.38
0121A		<1%	102	$101.29
G0010	Administration of hepatitis b vaccine	<1%	370	$96.65
98967		<1%	24	$92.12
91300		<1%	6,515	$91.68
96380		<1%	186	$91.01
84597		<1%	13	$90.87
A4627	Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler	<1%	28	$90.45
83529		<1%	41	$87.37
84591		<1%	31	$87.13
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,299	$86.51
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	453	$79.40
J3411	Injection, thiamine hcl, 100 mg	<1%	414	$79.18
0173A		<1%	133	$79.08
69220		<1%	13	$78.97
00918		<1%	17	$77.12
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	188	$73.42
J2540	Injection, penicillin g potassium, up to 600,000 units	<1%	124	$71.34
J2470	Injection, pantoprazole sodium, 40 mg	<1%	178	$69.07
81000		<1%	131	$61.79
J9267	Injection, paclitaxel, 1 mg	<1%	1,284	$60.64
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	116	$55.44
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	28	$55.24
J1171	Injection, hydromorphone, 0.1 mg	<1%	303	$54.65
88364		<1%	16	$53.01
J2305	Injection, nitroglycerin, 5 mg	<1%	114	$52.54
36140		<1%	17	$49.86
87071		<1%	108	$49.56
A6449	Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard	<1%	925	$49.06
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	486	$47.24
72020		<1%	24	$47.03
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	689	$45.36
82435		<1%	94	$42.26
A9585	Injection, gadobutrol, 0.1 ml	<1%	534	$39.84
J1630	Injection, haloperidol, up to 5 mg	<1%	236	$38.08
83051		<1%	18	$37.31
85347		<1%	39	$36.03
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	137	$35.44
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	349	$34.68
01402		<1%	44	$33.55
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	16	$32.74
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	84	$31.36
J7507	Tacrolimus, immediate release, oral, 1 mg	<1%	72	$29.01
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	668	$26.02
87430		<1%	68	$25.98
L8509	Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type	<1%	14	$25.85
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	311	$21.40
96167		<1%	21	$20.13
89343		<1%	70	$20.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	6,083	$18.92
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	222	$18.91
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	104	$15.70
91312		<1%	3,241	$14.88
87185		<1%	18	$14.36
90611		<1%	93	$13.89
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	217	$11.68
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	14	$8.46
J0736	Injection, clindamycin phosphate, 300 mg	<1%	47	$7.15
J0456	Injection, azithromycin, 500 mg	<1%	316	$6.26
91305		<1%	1,005	$5.94
91307		<1%	802	$5.44
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,734	$5.29
91308		<1%	750	$4.98
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	259	$4.74
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	438	$3.29
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	147	$3.20
Q4049	Finger splint, static	<1%	79	$2.63
J1956	Injection, levofloxacin, 250 mg	<1%	15	$2.30
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	<1%	183	$1.58
91315		<1%	108	$1.06
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	355	$0.87
J0290	Injection, ampicillin sodium, 500 mg	<1%	31	$0.82
91306		<1%	17	$0.14
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	14	$0.14
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	16	$0.13
91303		<1%	13	$0.11
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	422	$0.07
3078F		<1%	295,319	$0.02
3074F		0%	326,000	$0.00
3075F		0%	16,734	$0.00
3079F		0%	46,930	$0.00
3080F		0%	2,184	$0.00
3044F		0%	225	$0.00
1220F		0%	105	$0.00
31629		0%	24	$0.00
1123F		0%	370	$0.00
1111F		0%	91	$0.00
A9561	Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries	0%	199	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	95	$0.00
V2632	Posterior chamber intraocular lens	0%	238	$0.00
87808		0%	43	$0.00
J2787	Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml	0%	16	$0.00
J1110	Injection, dihydroergotamine mesylate, per 1 mg	0%	47	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	60	$0.00
91317		0%	42	$0.00
C1753	Catheter, intravascular ultrasound	0%	18	$0.00
C1733	Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip	0%	15	$0.00
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	0%	12	$0.00
82985		0%	15	$0.00
C1759	Catheter, intracardiac echocardiography	0%	27	$0.00
A9567	Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries	0%	18	$0.00
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	0%	30	$0.00
3077F		0%	11,214	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	2,050	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	2,229	$0.00
3046F		0%	200	$0.00
C2625	Stent, non-coronary, temporary, with delivery system	0%	213	$0.00
00402		0%	405	$0.00
99091		0%	15	$0.00
C1758	Catheter, ureteral	0%	171	$0.00
1124F		0%	18	$0.00
98966		0%	16	$0.00
3051F		0%	12	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	52	$0.00
43450		0%	16	$0.00
J3250	Injection, trimethobenzamide hcl, up to 200 mg	0%	38	$0.00
0502F		0%	16	$0.00
C1762	Connective tissue, human (includes fascia lata)	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)

Same official

Other billing entities under LARAWAY, DENNIS

Full network →

Provider	Location	Paid
Akron General Medical Center	Akron, OH	$98.99M
Cleveland Clinic Mercy Hospital	Canton, OH	$86.97M
Memorial Hermann Health System	Houston, TX	$84.45M
Fairview Hospital	Cleveland, OH	$62.42M
Lutheran Hospital	Cleveland, OH	$41.49M
Cleveland Clinic Health System - East Region	Euclid, OH	$40.67M
Memorial Hermann Health System	Houston, TX	$39.46M
Cleveland Clinic Children's Hospital for Rehabilitation	Cleveland, OH	$36.43M
Cleveland Clinic Health System - East Region	Mayfield Hts, OH	$32.76M
Cleveland Clinic Health System - East Region	Warrensville Heights, OH	$31.44M
Partners Physician Group	Akron, OH	$28.37M
Marymount Hospital INC	Garfield Heights, OH	$28.02M
Memorial Hermann Health System	Humble, TX	$26.79M
Martin Memorial Medical Center INC	Stuart, FL	$26.03M
The Union Hospital Association	Dover, OH	$20.23M
Lodi Community Hospital	Lodi, OH	$17.53M
Clinic Medical Services Company LLC	Cleveland, OH	$10.82M
Cleveland Clinic Home Care Services	Independence, OH	$10.76M
Indian River Memorial Hospital INC	Vero Beach, FL	$9.27M
Memorial Hermann Health System	Sugar Land, TX	$9.14M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.